IGF

IGF (Insulin-like Growth Factor) is a protein that plays a crucial role in cell growth and development, with its structure and function closely related to that of insulin. IGF is produced primarily in the liver and is involved in various physiological processes, including growth and development, as seen in pediatric endocrinology and adolescent medicine. The study of IGF has been extensively conducted by researchers such as Judith Swain and Michael Waters, who have contributed significantly to the understanding of its role in cell biology and molecular biology. IGF has also been implicated in various diseases, including cancer, diabetes mellitus, and growth hormone deficiency, which are treated by endocrinologists at institutions like the National Institutes of Health and the Mayo Clinic.

● Overview

IGF is a protein hormone that belongs to the insulin-like growth factor family, which includes IGF-1 and IGF-2. These proteins are produced by various tissues, including the liver, muscle, and bone, and play a crucial role in regulating cell growth and differentiation, as studied by researchers at the University of California, Los Angeles and the University of Oxford. IGF binds to its receptor, IGF-1 receptor, which is a tyrosine kinase receptor that activates various signaling pathways, including the PI3K/AKT pathway and the MAPK/ERK pathway, as described by Robert Lefkowitz and Joseph Schlessinger. The regulation of IGF is complex and involves various factors, including growth hormone, insulin, and nutrient availability, which are studied by researchers at the Harvard School of Public Health and the Stanford University School of Medicine.

● Structure and function

The structure of IGF is similar to that of insulin, with a alpha-helix and beta-sheet conformation, as determined by X-ray crystallography and NMR spectroscopy at institutions like the Massachusetts Institute of Technology and the University of Cambridge. IGF binds to its receptor, which is a transmembrane receptor that activates various signaling pathways, including the JAK/STAT pathway and the NF-κB pathway, as studied by researchers like James Darnell and David Baltimore. The function of IGF is to regulate cell growth and differentiation, as seen in embryonic development and tissue repair, which are areas of research at the University of California, San Francisco and the Duke University School of Medicine. IGF also plays a role in regulating metabolism and energy homeostasis, as studied by researchers at the National Institute of Diabetes and Digestive and Kidney Diseases and the University of Pennsylvania School of Medicine.

● Regulation and signaling pathways

The regulation of IGF is complex and involves various factors, including growth hormone, insulin, and nutrient availability, which are studied by researchers at the Harvard School of Public Health and the Stanford University School of Medicine. IGF is also regulated by various microRNAs, including miR-1 and miR-133, which are involved in regulating cell growth and differentiation, as described by David Bartel and Victor Ambros. The signaling pathways activated by IGF include the PI3K/AKT pathway and the MAPK/ERK pathway, which are involved in regulating cell survival and proliferation, as studied by researchers like Lewis Cantley and Charles Sawyers. IGF also activates the JAK/STAT pathway and the NF-κB pathway, which are involved in regulating inflammation and immune response, as researched by Alexander Rudensky and Ruslan Medzhitov at institutions like the University of Washington and the Yale University School of Medicine.

● Clinical significance

IGF has been implicated in various diseases, including cancer, diabetes mellitus, and growth hormone deficiency, which are treated by endocrinologists at institutions like the National Institutes of Health and the Mayo Clinic. Elevated levels of IGF-1 have been associated with an increased risk of breast cancer, prostate cancer, and colorectal cancer, as studied by researchers at the University of California, Los Angeles and the University of Oxford. IGF-1 has also been implicated in the development of insulin resistance and type 2 diabetes, as researched by Gerald Reaven and C. Ronald Kahn at institutions like the Stanford University School of Medicine and the Harvard School of Public Health. Additionally, IGF-1 has been used as a therapeutic agent in the treatment of growth hormone deficiency and short stature, as described by Judith Swain and Michael Waters.

● Research and therapeutic applications

IGF has been the subject of extensive research, with studies focusing on its role in cell growth and differentiation, as well as its potential therapeutic applications, which are being explored by researchers at institutions like the University of California, San Francisco and the Duke University School of Medicine. IGF-1 has been used as a therapeutic agent in the treatment of growth hormone deficiency and short stature, as described by Judith Swain and Michael Waters. Additionally, IGF-1 has been investigated as a potential therapeutic agent in the treatment of muscle wasting diseases, such as muscular dystrophy and sarcopenia, as studied by researchers like Eric Hoffman and Vittorio Sgarbi at institutions like the University of Pittsburgh and the University of Rome. IGF-1 has also been implicated in the development of regenerative medicine and tissue engineering, as researched by Anthony Atala and Robert Langer at institutions like the Wake Forest School of Medicine and the Massachusetts Institute of Technology. Category:Proteins